California Retina Consultants   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Santa Barbara CA United States (1969)

Organization Overview

First Clinical Trial
2005
NCT00915837
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

California Retina Consultants | California Retinal Consultants | Nathan Steinle

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Choroidal Neovascularization (Phase 2)

Diabetic Retinopathy (Phase 4)

Edema (Phase 4)

Glaucoma (Phase 2)

Glaucoma, Neovascular (Phase 2)

Macular Degeneration (Phase 4)

Macular Edema (Phase 4)

Neovascularization, Pathologic (Phase 2)

Retinal Perforations (Phase 2)

Retinal Vein Occlusion (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial APIs: 9